Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IDEXX Laboratories, Inc. - Common Stock
(NQ:
IDXX
)
526.44
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IDEXX Laboratories, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge
↗
January 23, 2023
The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
Via
Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
↗
January 23, 2023
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better.
Via
Investor's Business Daily
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
↗
January 09, 2023
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.
Via
Investor's Business Daily
GE HealthCare Technologies Soars As GE Legacy Business Plummets
January 05, 2023
Wednesday marked the trading debut of GE HealthCare Technologies, the health-focused business spun off from General Electric. Shares rose 12%.
Via
MarketBeat
Topics
Stocks
What Does IDEXX Laboratories' Debt Look Like?
↗
January 04, 2023
Shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) moved higher by 28.56% in the past three months. Before having a look at the importance of debt, let's look at how much debt IDEXX Laboratories has.
Via
Benzinga
Golden Cross Appears Before IDEXX Laboratories Investors
↗
December 27, 2022
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know
↗
November 15, 2022
Via
Benzinga
Why IDEXX Stock Popped Today
↗
November 01, 2022
The animal healthcare company beat estimates on the top and bottom lines.
Via
The Motley Fool
Where IDEXX Laboratories Stands With Analysts
↗
July 21, 2022
Analysts have provided the following ratings for IDEXX Laboratories (NASDAQ:IDXX) within the last quarter:
Via
Benzinga
3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023
↗
December 26, 2022
By focusing on her interests, I hope to show my daughter that fascinating businesses are all around her.
Via
The Motley Fool
Looking Into IDEXX Laboratories's Return On Capital Employed
↗
November 08, 2022
Pulled from Benzinga Pro data, IDEXX Laboratories (NASDAQ:IDXX) posted Q3 earnings of $180.94 million, an increase from Q2 of 37.1%. Sales dropped to $841.66 million, a 2.19% decrease between...
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
↗
November 02, 2022
Gainers
Via
Benzinga
The 3 Best Pet Stocks to Buy Now
↗
July 04, 2022
Pets are a big part of the family in America, and that trend is only growing. Here are some top pet stocks to help you profit from the trend.
Via
InvestorPlace
Gartner, Sony, Uber And Other Big Gainers From Tuesday
↗
November 02, 2022
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
↗
November 01, 2022
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Via
Benzinga
IDEXX Laboratories: Q3 Earnings Insights
↗
November 01, 2022
IDEXX Laboratories (NASDAQ:IDXX) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Peering Into IDEXX Laboratories's Recent Short Interest
↗
October 31, 2022
IDEXX Laboratories's (NASDAQ:IDXX) short percent of float has risen 14.54% since its last report. The company recently reported that it has 2.37 million shares sold short, which is 3.23% of all regular...
Via
Benzinga
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
↗
October 31, 2022
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 12.17% on an annualized basis producing an average annual return of 22.65%. Currently, IDEXX Laboratories has a...
Via
Benzinga
Expert Ratings for IDEXX Laboratories
↗
October 17, 2022
Over the past 3 months, 7 analysts have published their opinion on IDEXX Laboratories (NASDAQ:IDXX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
Don’t Miss the Turnaround in These 3 Stocks
↗
October 04, 2022
Of the 48 companies down more than double the S&P 500 year-to-date, these are the three stocks to buy for a turnaround in 2023.
Via
InvestorPlace
Recap: IDEXX Laboratories Q2 Earnings
↗
August 02, 2022
IDEXX Laboratories (NASDAQ:IDXX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $3,700 Today
↗
August 01, 2022
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 1.93% on an annualized basis producing an average annual return of 9.0%. Currently, IDEXX Laboratories has a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
↗
July 25, 2022
Upgrades
Via
Benzinga
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday
↗
July 21, 2022
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-market...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022
↗
July 21, 2022
Upgrades
Via
Benzinga
7 Wildly Oversold S&P 500 Stocks to Buy Now
↗
July 20, 2022
These seven S&P 500 stocks to buy have crashed amid 2022's market turmoil and are now set for a swift rebound.
Via
InvestorPlace
$1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
↗
July 14, 2022
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 5.54% on an annualized basis producing an average annual return of 13.53%. Currently, IDEXX Laboratories has a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
↗
July 12, 2022
Upgrades
Via
Benzinga
How Is The Market Feeling About IDEXX Laboratories?
↗
July 12, 2022
IDEXX Laboratories's (NASDAQ:IDXX) short percent of float has risen 7.34% since its last report. The company recently reported that it has 1.95 million shares sold short, which is...
Via
Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
↗
June 29, 2022
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 9.28%. Currently, IDEXX Laboratories has a...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.